More than 80% of the US elderly population dies from coronary heart disease, but the benefits of statin therapy are not realized. These drugs are frequently underprescribed to elderly patients because few relevant age-specific data are available. This Review draws together the findings from major studies and assesses the value of statin use in the elderly.
- O Christopher Raffel
- Harvey D White